Relevance. Cryopreserved placenta extract (CPE) increase the resistance of the mucous membrane of the gastrointestinal tract to the damaging effects of nonsteroidal anti-inflammatory drugs. Preventive administration of CPE can reduce the ulcerogenic effect of meloxicam, ibuprofen, diclofenac sodium (DS) and others. There is evidence of CPE's own anti-inflammatory activity, which can be successfully combined with the pharmacological properties of nonsteroidal anti-inflammatory drugs, while improving their safety profile.
Objective: to characterize the therapeutic activity of the combined use of CPE and DS according to hematological parameters in the model of experimental rheumatoid arthritis (RA).
Materials and methods. Studies were performed on 28 nonlinear laboratory rats. The rats were divided into 4 groups: I (n = 7) – intact rats; II (n = 7) – rats with experimental RA; ІІІ (n = 7) – rats with experimental RA, treated with DN; IV (n = 7) – rats with experimental RA, treated with DN and CPE. Adjuvant arthritis was modeled by subplantar administration of complete Freund's adjuvant. Treatment was performed from 14 to 28 days. CPE was administered on days 14, 17, 20, 23 and 26, and DS – daily. Blood tests were performed on day 28 of the experiment.
Results. The combined use of CPE and DS is accompanied by a more pronounced leveling of inflammatory signs by hematological parameters – erythrocyte clotting rate decreased by 72.2% (p<0.001), and the number of leukocytes decreased by 54.81% (p<0.001) relative to rats with adjuvant arthritis without treatment. There was a leveling of signs of anemia of chronic inflammation – the level of hemoglobin and erythrocytes increased (p<0,001) by 17.6% and 36.8%, respectively, relative to rats with adjuvant arthritis without treatment.
Conclusions. The combined use of CPE and DS is superior in therapeutic activity to monotherapy with this nonsteroidal anti-inflammatory drug of experimental rheumatoid arthritis.
Anikin GS, Stozhkova IV, Kukes VG. NSAIDs: safety from the point of evidence-based medicine. Consilium Medicum. 2017; 19: 28-32. [in Ukrainian] DOI: 10.26442/2075-1753_126.96.36.199-32
Wasserman A. Rheumatoid Arthritis: Common Questions About Diagnosis and Management. American Family Physician. 2018;97(7):455-62.
Publisher Site: https://familydoctor.org/condition/rheumatoid-arthritis/
Woude D, Helm-van Mil HM. Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Practice & Research Clinical Rheumatology. 2018; 32 (2): 174-87. DOI: 10.1016/j.berh.2018.10.005.
Otón T, Carmona L. The epidemiology of established rheumatoid arthritis. Best Practice & Research Clinical Rheumatology. 2019; 33 (5): 101477. DOI: 10.1016/j.berh.2019.101477.
Ghosh N, Kolade OO, Shontz E, Rosenthal Y, Zuckerman JD, Bosco JA 3rd, Virk MS. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Their Effect on Musculoskeletal Soft-Tissue Healing: A Scoping Review. The Journal of Bone and Joint Surgery. 2019; 7 (12): e4. DOI: 10.2106/JBJS.RVW.19.00055.
Publisher Site: https://journals.lww.com/jbjsreviews/Abstract/2019/12000/Nonsteroidal_Anti_Inflammatory_Drugs__NSAIDs__and.2.aspx https://journals.lww.com/jbjsreviews/Abstract/2019/12000/Nonsteroidal_Anti_Inflammatory_Drugs__NSAIDs__and.2.aspx
Cunningham K, Candelario DM, Angelo LB. Nonsteroidal Anti-Inflammatory Drugs: Updates on Dosage Formulations and Adverse Effects. Orthopaedic Nursing. 2020; 39 (6):408-13. DOI: 10.1097/NOR.0000000000000713.
Satybaldyev AM, Karateev AE. What is safer for the gastrointestinal-tract: Coxibs or meloxicam? Modern Rheumatology. 2017; 11 (1): 72-8. [in Russian]. DOI: 10.14412/1996-7012-2017-1-72-78.
Publisher Site: https://mrj.ima-press.net/mrj/article/view/742
Bacchi S, Palumbo P, Sponta A, Coppolino MF. Clinical pharmacology of non-steroidal anti-inflammatory drugs: a review. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry. 2012; 11 (1): 52-64. DOI: 10.2174/187152312803476255.
Publisher Site: https://www.eurekaselect.com/102932/article
Hladkykh FV, Chyzh MO. Modulation of meloxicam-induced changes in gastrointestinal and motor activity of the stomach by applying placenta cryoextract. Proceedings of the Shevchenko Scientific Society. Medical Sciences. 2021; 64 (1): 84-94. DOI: 10.25040/ntsh2021.01.08.
Publisher Site: https://mspsss.org.ua/index.php/journal/article/view/400
Stefanov OV. Preclinical studies of drugs: guidelines. Kyiv: Avicenna; 2001. 527 p. [in Ukrainian].
Publisher Site: https://www.twirpx.com/file/537410/
Rybolovlev UR, Rybolovlev RS. Dosage of substances for mammals by constants of biological activity. Reports of the USSR Academy of Sciences. 1979; 247 (6): 1513-6. [in Russian].
Goltsev AN, ed. Placenta: cryopreservation, clinical use. Kharkiv, 2013. 268 p. [in Russian].
Karateev AE, Nasonov EL, Ivashkin VT, Martynov AI, Yakhno NN, Arutyunov GP, Alekseeva LI, Abuzarova GR, Evseev MA, Kukushkin ML, Kopenkin SS, Lila AM, Lapina TL, Novikova DS, Popkova TV, Rebrov AP, Skorobogatykh KV, Chichasova NV. Rational use of nonsteroidal anti-inflammatory drugs. Clinical guideline. Rheumatology Science and Practice. 2018; 56: 1-29. [in Russian]. DOI: 10.14412/1995-4484-2018-1-29.
Publisher Site: https://rsp.mediar-press.net/rsp/article/view/2536
Chen Y, Xu W, Yang H, Shao M, Xu S, Deng J, Gao X, Liu H, Shuai Z, Xu S, Pan F. Serum Levels of Hepcidin in Rheumatoid Arthritis and Its Correlation with Disease Activity and Anemia: A Meta-analysis. Immunological Investigations. 2021; 50 (2-3): 243-58. DOI: 10.1080/08820139.2020.1742731.
Sato H, Takai C, Kazama JJ, Wakamatsu A, Hasegawa E, Kobayashi D, Kondo N, Nakatsue T, Abe A, Ito S, Ishikawa H, Kuroda T, Suzuki Y, Narita I. Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis. Scientific Reports. 2020; 10 (1): 9882. DOI: 10.1038/s41598-020-66945-3.
Publisher Site: https://www.nature.com/articles/s41598-020-66945-3
PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303107/
Sahebari M, Rezaieyazdi Z, Hashemy SI, Khorasani S, Shahgordi S, Alizadeh MK, Ghaeni A, Khodashahi M. Serum hepcidin level and rheumatoid arthritis disease activity. European Journal of Rheumatology. 2018; 6 (2): 76-80. DOI: 10.5152/eurjrheum.2018.18114.
PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467328/
This work is licensed under a Creative Commons Attribution 4.0 International License.